Enovis Corp
(LTS:0I1B)
$
48.35
-0.10705 (-0.22%)
Market Cap: 2.73 Bil
Enterprise Value: 4.11 Bil
PE Ratio: 0
PB Ratio: 0.82
GF Score: 68/100 Enovis Corp at Evercore ISI HealthCONx Conference Transcript
Nov 29, 2023 / 03:00PM GMT
Release Date Price:
$50.11
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team
Thanks everyone for joining us this morning, pleasure to have with us Enovis. Enovis is a very interesting company, perhaps not so familiar with some of the MedTech guys, but investors, certainly an interesting story to tell. From the company, we have CEO, Matt Trerotola; and CFO, Ben Berry. In the audience, we have Kyle Rose, who heads Investor Relations and I'm Vijay Kumar, who heads MedTech and Life Sciences at Evercore.
With that, Matt and Ben, thanks for the time this morning.
Matthew L. Trerotola
Enovis Corporation - CEO & Chairman
Great to be here Vijay.
Phillip Benjamin Berry
Enovis Corporation - Senior VP & CFO
Thanks, Vijay.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot